1 mg retatrutide New GLP-1 obesity drug, retatrutide, shows added benefits New Weight Loss Drug Retatrutide:

Preparation for Microdosing GLP-1 Medications Proper preparation can make your experience with GLP-1 microdosing smoother and more effective

You Have No Contraindications During your initial consultation, your provider will screen for any conditions that may make GLP1 weight loss injections unsuitable

Recalculate the units per dose

Its not known if Saxenda increases the risk of thyroid cancer in humans

71 concluded that the increased risk of gallstone formation is not fully explained by weight loss alone, suggesting that the impact of GLP-1RAs on gallbladder motility and bile composition may contribute directly to gallstone risk

( )